Literature DB >> 26910516

Heterogeneous Optimization Framework: Reproducible Preprocessing of Multi-Spectral Clinical MRI for Neuro-Oncology Imaging Research.

Mikhail Milchenko1, Abraham Z Snyder2, Pamela LaMontagne2, Joshua S Shimony2, Tammie L Benzinger2, Sarah Jost Fouke3, Daniel S Marcus2.   

Abstract

Neuroimaging research often relies on clinically acquired magnetic resonance imaging (MRI) datasets that can originate from multiple institutions. Such datasets are characterized by high heterogeneity of modalities and variability of sequence parameters. This heterogeneity complicates the automation of image processing tasks such as spatial co-registration and physiological or functional image analysis. Given this heterogeneity, conventional processing workflows developed for research purposes are not optimal for clinical data. In this work, we describe an approach called Heterogeneous Optimization Framework (HOF) for developing image analysis pipelines that can handle the high degree of clinical data non-uniformity. HOF provides a set of guidelines for configuration, algorithm development, deployment, interpretation of results and quality control for such pipelines. At each step, we illustrate the HOF approach using the implementation of an automated pipeline for Multimodal Glioma Analysis (MGA) as an example. The MGA pipeline computes tissue diffusion characteristics of diffusion tensor imaging (DTI) acquisitions, hemodynamic characteristics using a perfusion model of susceptibility contrast (DSC) MRI, and spatial cross-modal co-registration of available anatomical, physiological and derived patient images. Developing MGA within HOF enabled the processing of neuro-oncology MR imaging studies to be fully automated. MGA has been successfully used to analyze over 160 clinical tumor studies to date within several research projects. Introduction of the MGA pipeline improved image processing throughput and, most importantly, effectively produced co-registered datasets that were suitable for advanced analysis despite high heterogeneity in acquisition protocols.

Entities:  

Keywords:  DSC imaging; Data modeling; Diffusion imaging; Knowledge representation; MRI; Neuro-oncology imaging; Spatial co-registration

Mesh:

Year:  2016        PMID: 26910516      PMCID: PMC4899239          DOI: 10.1007/s12021-016-9296-7

Source DB:  PubMed          Journal:  Neuroinformatics        ISSN: 1539-2791


  26 in total

1.  Improving lesion-symptom mapping.

Authors:  Chris Rorden; Hans-Otto Karnath; Leonardo Bonilha
Journal:  J Cogn Neurosci       Date:  2007-07       Impact factor: 3.225

Review 2.  Brain functional localization: a survey of image registration techniques.

Authors:  Ali Gholipour; Nasser Kehtarnavaz; Richard Briggs; Michael Devous; Kaundinya Gopinath
Journal:  IEEE Trans Med Imaging       Date:  2007-04       Impact factor: 10.048

3.  The Extensible Neuroimaging Archive Toolkit: an informatics platform for managing, exploring, and sharing neuroimaging data.

Authors:  Daniel S Marcus; Timothy R Olsen; Mohana Ramaratnam; Randy L Buckner
Journal:  Neuroinformatics       Date:  2007

4.  Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

Authors:  B Fischl; M I Sereno; A M Dale
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

5.  Comparative study of standard space and real space analysis of quantitative MR brain data.

Authors:  Benjamin S Aribisala; Jiabao He; Andrew M Blamire
Journal:  J Magn Reson Imaging       Date:  2011-06       Impact factor: 4.813

6.  Predicting a multi-parametric probability map of active tumor extent using random forests.

Authors:  Fred W Prior; Sarah J Fouke; Tammie Benzinger; Alicia Boyd; Michael Chicoine; Sharath Cholleti; Matthew Kelsey; Bart Keogh; Lauren Kim; Mikhail Milchenko; David G Politte; Stephen Tyree; Kilian Weinberger; Daniel Marcus
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

7.  Differences in dynamic susceptibility contrast MR perfusion maps generated by different methods implemented in commercial software.

Authors:  Laura Orsingher; Silvia Piccinini; Girolamo Crisi
Journal:  J Comput Assist Tomogr       Date:  2014 Sep-Oct       Impact factor: 1.826

8.  Registration of [18F]FDG microPET and small-animal MRI.

Authors:  Douglas J Rowland; Joel R Garbow; Richard Laforest; Abraham Z Snyder
Journal:  Nucl Med Biol       Date:  2005-08       Impact factor: 2.408

9.  The comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkers.

Authors:  Sarah Jost Fouke; Tammie L Benzinger; Mikhail Milchenko; Pamela LaMontagne; Joshua S Shimony; Michael R Chicoine; Keith M Rich; Albert H Kim; Eric C Leuthardt; Bart Keogh; Daniel S Marcus
Journal:  Neurosurgery       Date:  2014-01       Impact factor: 4.654

10.  Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas.

Authors:  Chadi Hlaihel; Laurent Guilloton; Jacques Guyotat; Nathalie Streichenberger; Jerome Honnorat; François Cotton
Journal:  J Neurooncol       Date:  2009-08-29       Impact factor: 4.130

View more
  3 in total

Review 1.  Sensor, Signal, and Imaging Informatics.

Authors:  W Hsu; S Park; Charles E Kahn
Journal:  Yearb Med Inform       Date:  2017-09-11

2.  Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation.

Authors:  Qing Wang; Gloria J Guzmán Pérez-Carrillo; Maria Rosana Ponisio; Pamela LaMontagne; Sonika Dahiya; Daniel S Marcus; Mikhail Milchenko; Joshua Shimony; Jingxia Liu; Gengsheng Chen; Amber Salter; Parinaz Massoumzadeh; Michelle M Miller-Thomas; Keith M Rich; Jonathan McConathy; Tammie L S Benzinger; Yong Wang
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

3.  A feasibility study to evaluate early treatment response of brain metastases one week after stereotactic radiosurgery using perfusion weighted imaging.

Authors:  Jiayi Huang; Mikhail Milchenko; Yuan J Rao; Pamela LaMontagne; Christopher Abraham; Clifford G Robinson; Yi Huang; Joshua S Shimony; Keith M Rich; Tammie Benzinger
Journal:  PLoS One       Date:  2020-11-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.